News
Video
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
With growing popularity, GLP-1 RAs antidiabetes and antiobesity drugs have taken a place in contemporary medicine on par with HIV/AIDS drugs in the 1990s and birth control drugs in the 1950s and 1960s — and maybe surpassed those medicines that revolutionized health care. Alliance for Pharmacy Compounding CEO Scott Brunner, CAE, explains the context of physician prescription and patient demand in just the last two to three years.